160
Views
60
CrossRef citations to date
0
Altmetric
Original Paper

Use of Inflammatory Markers for Early Detection of Bacteraemia in Patients with Febrile Neutropenia

, , , , , & show all
Pages 365-371 | Received 21 Aug 2003, Accepted 02 Mar 2004, Published online: 08 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (6)

Deniz Guven Karakurt, Ugur Demirsoy, Funda Corapcioglu, Selim Oncel, Meriban Karadogan & Emin Sami Arisoy. (2014) Do Proinflammatory Cytokine Levels Predict Serious Complication Risk of Infection in Pediatric Cancer Patients?. Pediatric Hematology and Oncology 31:5, pages 415-424.
Read now
Auni Juutilainen, Sari Hämäläinen, Kari Pulkki, Taru Kuittinen, Tapio Nousiainen, Esa Jantunen & Irma Koivula. (2011) Biomarkers for bacteremia and severe sepsis in hematological patients with neutropenic fever: multivariate logistic regression analysis and factor analysis. Leukemia & Lymphoma 52:12, pages 2349-2355.
Read now
Sari Hämäläinen, Auni Juutilainen, Taru Kuittinen, Tapio Nousiainen, Irma Matinlauri, Kari Pulkki, Irma Koivula & Esa Jantunen. (2010) Serum amino-terminal pro-brain natriuretic peptide in hematological patients with neutropenic fever: a prospective comparison with C-reactive protein. Leukemia & Lymphoma 51:6, pages 1040-1046.
Read now
Auni Juutilainen, Sari Hämäläinen, Irma Matinlauri, Taru Kuittinen, Tapio Nousiainen, Kari Pulkki, Irma Koivula & Esa Jantunen. (2010) Serial plasma lactate measurements in haematological patients with neutropenic fever. Scandinavian Journal of Infectious Diseases 42:2, pages 102-108.
Read now
Sari Hämäläinen, Taru Kuittinen, Irma Matinlauri, Tapio Nousiainen, Irma Koivula & Esa Jantunen. (2008) Neutropenic fever and severe sepsis in adult acute myeloid leukemia (AML) patients receiving intensive chemotherapy: Causes and consequences. Leukemia & Lymphoma 49:3, pages 495-501.
Read now
Ra Tuma, Ng Almyroudis, Sj Sohn, K Panageas, Rd Rice, D Galinkin, M Blain, M Montefusco, Eg Pamer, Sd Nimer & T Kewalramani. (2006) The serum IL-12:IL-6 ratio reliably distinguishes infectious from non-infectious causes of fever during autologous stem cell transplantation. Cytotherapy 8:4, pages 327-334.
Read now

Articles from other publishers (54)

Christopher J. Coyne, Edward M. Castillo, Rebecca A. Shatsky & Theodore C. Chan. (2022) Procalcitonin as a Predictive Tool for Death and ICU Admission among Febrile Neutropenic Patients Visiting the Emergency Department. Medicina 58:8, pages 985.
Crossref
Chung-Jong Kim. (2022) Current Status of Antibiotic Stewardship and the Role of Biomarkers in Antibiotic Stewardship Programs. Infection & Chemotherapy 54:4, pages 674.
Crossref
Yuliya Nikolaevna Dubinina, V.O. Sarzhevskii & V.Ya. Melnichenko. (2019) Role of Biochemical Inflammatory Markers in Patients with Chemotherapy-Induced Neutropenia. Clinical oncohematology 12:4, pages 101-107.
Crossref
Klaus Hackner, Waltraud Riegler, Sabin Handzhiev, Rosemarie Bauer, Jan Veres, Manuela Speiser, Karin Meisinger & Peter Errhalt. (2017) Fever after bronchoscopy: serum procalcitonin enables early diagnosis of post-interventional bacterial infection. BMC Pulmonary Medicine 17:1.
Crossref
Ana Madera Rojas, Sonia Cuervo Maldonado, Ricardo Sánchez, Julio Gómez Rincón & Carlos Bermúdez. (2017) Cuantificación de citoquinas y su relación con la presencia de bacteriemia en leucemias agudas y neutropenia febril postquimioterapia. Revista Colombiana de Cancerología 21:3, pages 152-159.
Crossref
Stella Sala Soares Lima, Vandack Nobre, Roberta Maia de Castro Romanelli, Wanessa Trindade Clemente, Henrique Neves da Silva Bittencourt, Ana Catarina Mourão Melo, Luciana Caetano Botelho Salomão & José Carlos Serufo. (2016) Procalcitonin-guided protocol is not useful to manage antibiotic therapy in febrile neutropenia: a randomized controlled trial. Annals of Hematology 95:7, pages 1169-1176.
Crossref
Shin Ahn, Yoon-Seon Lee, Jae-Lyun Lee, Kyung Soo Lim & Sung-Cheol Yoon. (2015) A new prognostic model for chemotherapy-induced febrile neutropenia. International Journal of Clinical Oncology 21:1, pages 46-52.
Crossref
Chun-Wei Wu, Jiunn-Yih Wu, Chun-Kuei Chen, Shiau-Ling Huang, Shou-Chien Hsu, Meng-tse Gabriel Lee, Shy-Shin Chang & Chien-Chang Lee. (2015) Does procalcitonin, C-reactive protein, or interleukin-6 test have a role in the diagnosis of severe infection in patients with febrile neutropenia? A systematic review and meta-analysis. Supportive Care in Cancer 23:10, pages 2863-2872.
Crossref
Marc Gregory Y. Yu, Ralph Elvi M. Villalobos, Ma. Jasmin Marinela C. Juan-Bartolome & Regina P. Berba. (2015) Predictors of Outcome and Severity in Adult Filipino Patients with Febrile Neutropenia. Advances in Hematology 2015, pages 1-6.
Crossref
Muhammad H. Abbas, Muhammad N. Choudhry, Numan Hamza, Baqar Ali, Ali A. Amin & Basil J. Ammori. (2014) Admission Levels of Serum Amyloid A and Procalcitonin are More Predictive of the Diagnosis of Acute Appendicitis Compared With C-reactive Protein. Surgical Laparoscopy, Endoscopy & Percutaneous Techniques 24:6, pages 488-494.
Crossref
M Sato, H Nakasone, K Terasako-Saito, K Sakamoto, R Yamazaki, Y Tanaka, Y Akahoshi, H Nakano, T Ugai, H Wada, R Yamasaki, Y Ishihara, K Kawamura, M Ashizawa, S-i Kimura, M Kikuchi, A Tanihara, J Kanda, S Kako, J Nishida & Y Kanda. (2014) Prediction of infectious complications by the combination of plasma procalcitonin level and localized infection before allogeneic hematopoietic cell transplantation. Bone Marrow Transplantation 49:4, pages 553-560.
Crossref
Jiun‐Jen Lynn, Kuan‐Fu Chen, Yi‐Ming Weng & Te‐Fa Chiu. (2013) Risk factors associated with complications in patients with chemotherapy‐induced febrile neutropenia in emergency department. Hematological Oncology 31:4, pages 189-196.
Crossref
Shin Ahn, Yoon-Seon Lee, Kyung Soo Lim & Jae-Lyun Lee. (2013) Adding procalcitonin to the MASCC risk-index score could improve risk stratification of patients with febrile neutropenia. Supportive Care in Cancer 21:8, pages 2303-2308.
Crossref
R Aggarwal, D Bansal, F Bansal, N Nanda, P Ray, A Trehan & RK Marwaha. (2013) Interleukin-5, interleukin-6, interleukin-8 and tumour necrosis factor-alpha levels obtained within 24-h of admission do not predict high-risk infection in children with febrile neutropenia. Indian Journal of Medical Microbiology 31:3, pages 226-229.
Crossref
Robert S Phillips, Ros Wade, Thomas Lehrnbecher, Lesley A Stewart & Alex J Sutton. (2012) Systematic review and meta-analysis of the value of initial biomarkers in predicting adverse outcome in febrile neutropenic episodes in children and young people with cancer. BMC Medicine 10:1.
Crossref
Matti Vänskä, Irma Koivula, Esa Jantunen, Sari Hämäläinen, Anna-Kaisa Purhonen, Kari Pulkki & Auni Juutilainen. (2012) IL-10 combined with procalcitonin improves early prediction of complications of febrile neutropenia in hematological patients. Cytokine 60:3, pages 787-792.
Crossref
William Shomali, Ray Hachem, Anne‐Marie Chaftari, Ying Jiang, Ramez Bahu, Joseph Jabbour, Sammy Raad, Munirah Al Shuaibi, Iba Al Wohoush & Issam Raad. (2012) Can procalcitonin distinguish infectious fever from tumor‐related fever in non‐neutropenic cancer patients?. Cancer 118:23, pages 5823-5829.
Crossref
Rigina Sklavou, Kyriaki Karavanaki, Eleni Critselis, Lydia Kossiva, Maria Giannaki, Maria Tsolia, Vassilis Papadakis, Sophia Papargyri, Antonia Vlachou, Fotis Karantonis, Dimitris Gourgiotis & Sophia Polychronopoulou. (2012) Variation of serum C-reactive protein (CRP) over time in pediatric cancer patients with febrile illness and its relevance to identified pathogen. Clinical Biochemistry 45:15, pages 1178-1182.
Crossref
Shin Ahn & Yoon-Seon Lee. (2012) Predictive factors for poor prognosis febrile neutropenia. Current Opinion in Oncology 24:4, pages 376-380.
Crossref
Vincas Urbonas, Audronė Eidukaitė & Indrė Tamulienė. (2012) The Diagnostic Value of Interleukin-6 and Interleukin-8 for Early Prediction of Bacteremia and Sepsis in Children With Febrile Neutropenia and Cancer. Journal of Pediatric Hematology/Oncology 34:2, pages 122-127.
Crossref
Diego Andrés Bonilla, Sonia Isabel Cuervo & Julio César Gómez. (2012) Utilidad de la procalcitonina en pacientes adultos con neoplasias hematológicas y neutropenia febril posquimioterapia. Estado del arte. Infectio 16:4, pages 223-229.
Crossref
D. Torfoss, B. Sandstad, T. E. Mollnes, E. A. Høiby, H. Holte, J. Bjerner, T. Bjøro, G. Gaudernack, G. Kvalheim & S. Kvaløy. (2011) The Mild Inflammatory Response in Febrile Neutropenic Lymphoma Patients with Low Risk of Complications is More Pronounced in Patients Receiving Tobramycin Once Daily Compared with Three Times Daily. Scandinavian Journal of Immunology 74:6, pages 632-639.
Crossref
Auni Juutilainen, Sari Hämäläinen, Juuso Niemenpää, Taru Kuittinen, Kari Pulkki, Irma Koivula, Leo Niskanen & Esa Jantunen. (2011) Serum cortisol and inflammatory response in neutropenic fever. Annals of Hematology 90:12, pages 1467-1475.
Crossref
Anne-Claire Gac, Jean-Jacques Parienti, Sylvain Chantepie, Sabine Fradin, Xavier Le Coutour, Roland Leclercq & Oumedaly Reman. (2011) Dynamics of procalcitonin and bacteremia in neutropenic adults with acute myeloid leukemia. Leukemia Research 35:10, pages 1294-1296.
Crossref
Hana Hakim & Aditya H. Gaur. (2011) Initial Management of Fever and Neutropenia in a Child With Cancer—The Past, the Present, and the Future. Clinical Pediatric Emergency Medicine 12:3, pages 174-184.
Crossref
Chou-Han Lin, Ming Yao, Szu-Chun Hsu, Chao-Chi Ho, Ming-Tzer Lin, Chih-An Lin, Fu-Chang Hu, Chong-Jen Yu & Hwei-Fang Tien. (2011) Soluble triggering receptor expressed on myeloid cells-1 as an infection marker for patients with neutropenic fever*. Critical Care Medicine 39:5, pages 993-999.
Crossref
James Owen Robinson, Frédéric Lamoth, Frank Bally, Marlies Knaup, Thierry Calandra & Oscar Marchetti. (2011) Monitoring Procalcitonin in Febrile Neutropenia: What Is Its Utility for Initial Diagnosis of Infection and Reassessment in Persistent Fever?. PLoS ONE 6:4, pages e18886.
Crossref
Konrad Reinhart & Michael Meisner. (2011) Biomarkers in the Critically Ill Patient: Procalcitonin. Critical Care Clinics 27:2, pages 253-263.
Crossref
Irma Matinlauri, Auni Juutilainen, Sari Hämäläinen, Irma Koivula, Taru Kuittinen & Esa Jantunen. (2010) Fibrinogen and antithrombin in hematological patients with neutropenic fever. Open Medicine 5:4, pages 520-526.
Crossref
P. Marín Reina, I. Ruiz Alcántara, S. Vidal Micó, J.L. López-Prats Lucea & V. Modesto i Alapont. (2010) Exactitud del test de procalcitonina en el diagnóstico de bacteriemia oculta en pediatría: revisión sistemática y metanálisis. Anales de Pediatría 72:6, pages 403-412.
Crossref
Martijn D. de Kruif, Maarten Limper, Herman Gerritsen, C Arnold Spek, Dees P. M. Brandjes, Hugo ten Cate, Patrick M. Bossuyt, Pieter H. Reitsma & Eric C. M. van Gorp. (2010) Additional value of procalcitonin for diagnosis of infection in patients with fever at the emergency department. Critical Care Medicine 38:2, pages 457-463.
Crossref
Takuro Nishikawa, Yasuhiro Okamoto, Yuichi Kodama, Takayuki Tanabe, Yuichi Shinkoda & Yoshifumi Kawano. (2010) Serum derivative of reactive oxygen metabolites (d-ROMs) in pediatric hemato-oncological patients with neutropenic fever. Pediatric Blood & Cancer, pages n/a-n/a.
Crossref
Sari Hämäläinen, Auni Juutilainen, Irma Matinlauri, Taru Kuittinen, Esko Ruokonen, Irma Koivula & Esa Jantunen. (2009) Serum vascular endothelial growth factor in adult haematological patients with neutropenic fever: a comparison with C-reactive protein. European Journal of Haematology 83:3, pages 251-257.
Crossref
Daniel Bastian, Margareth Vislie Tamburstuen, Ståle Petter Lyngstadaas & Olav Reikerås. (2009) Local and systemic chemokine patterns in a human musculoskeletal trauma model. Inflammation Research 58:8, pages 483-489.
Crossref
K. M. HoS. C. Towler. (2009) A Comparison of Eosinopenia and C-Reactive Protein as a Marker of Bloodstream Infections in Critically Ill Patients: A Case Control Study. Anaesthesia and Intensive Care 37:3, pages 450-456.
Crossref
K. M. HoJ. Lipman. (2009) An Update on C-reactive Protein for Intensivists. Anaesthesia and Intensive Care 37:2, pages 234-241.
Crossref
Nuray Buyukberber, Süleyman Buyukberber, Alper Sevinc & Celalettin Camci. (2008) Cytokine concentrations are not predictive of bacteremia in febrile neutropenic patients. Medical Oncology 26:1, pages 55-61.
Crossref
Boris P Ehrenstein, Vera Ehrenstein, Christine Henke, Hans-Jörg Linde, Bernd Salzberger, Jürgen Schölmerich & Thomas Glück. (2008) Risk factors for negative blood cultures in adult medical inpatients – a retrospective analysis. BMC Infectious Diseases 8:1.
Crossref
Y. Sakr, C. Sponholz, F. Tuche, F. Brunkhorst & K. Reinhart. (2008) The Role of Procalcitonin in Febrile Neutropenic Patients: Review of the Literature. Infection 36:5.
Crossref
Michael Ellis. (2008) Febrile Neutropenia. Annals of the New York Academy of Sciences 1138:1, pages 329-350.
Crossref
Shigeo Fuji, Sung-Won Kim, Takahiro Fukuda, Shin-ichiro Mori, Satoshi Yamasaki, Yuriko Morita-Hoshi, Fusako Ohara-Waki, Yuji Heike, Kensei Tobinai, Ryuji Tanosaki & Yoichi Takaue. (2008) Preengraftment Serum C-Reactive Protein (CRP) Value May Predict Acute Graft-versus-Host Disease and Nonrelapse Mortality after Allogeneic Hematopoietic Stem Cell Transplantation. Biology of Blood and Marrow Transplantation 14:5, pages 510-517.
Crossref
Anastasia Antoniadou & Helen Giamarellou. (2007) Fever of Unknown Origin in Febrile Leukopenia. Infectious Disease Clinics of North America 21:4, pages 1055-1090.
Crossref
A. UYS, B.L. RAPOPORT, H. FICKL, P.W.A. MEYER & R. ANDERSON. (2007) Prediction of outcome in cancer patients with febrile neutropenia: comparison of the Multinational Association of Supportive Care in Cancer risk-index score with procalcitonin, C-reactive protein, serum amyloid A, and interleukins-1β, -6, -8 and -10. European Journal of Cancer Care 16:6, pages 475-483.
Crossref
Daiana Stolz, Andreas Stulz, Beat Müller, Alois Gratwohl & Michael Tamm. (2007) BAL Neutrophils, Serum Procalcitonin, and C-Reactive Protein To Predict Bacterial Infection in the Immunocompromised Host. Chest 132:2, pages 504-514.
Crossref
Alan E. Jones, James F. Fiechtl, Michael D. Brown, Jason J. Ballew & Jeffrey A. Kline. (2007) Procalcitonin Test in the Diagnosis of Bacteremia: A Meta-analysis. Annals of Emergency Medicine 50:1, pages 34-41.
Crossref
P. Hausfater. (2007) Le dosage de la procalcitonine en pratique clinique chez l'adulte. La Revue de Médecine Interne 28:5, pages 296-305.
Crossref
Anastasia Antoniadou & Helen Giamarellou. 2007. Fever of Unknown Origin. Fever of Unknown Origin 35 58 .
M. Parsa, S.N. Najafi .N. Jonaidi Jafari .M. Mohraz .A. Ghavamzadeh .B. Bahar .M. Izadi .M.H. Radfar .H. Ghofrani .. (2007) Diagnostic Relevance of Interleukin-6 and Tumor Necrosis Factor Alpha in Discriminating High Risk and Low Risk Groups in Febrile Patients with Neutropenia. Journal of Biological Sciences 7:2, pages 338-342.
Crossref
R.P.H. Peters, J.W.R. Twisk, M.A. van Agtmael & A.B.J. Groeneveld. (2006) The role of procalcitonin in a decision tree for prediction of bloodstream infection in febrile patients. Clinical Microbiology and Infection 12:12, pages 1207-1213.
Crossref
M. von Lilienfeld-Toal, A. Schneider, K. Orlopp, C. Hahn-Ast, A. Glasmacher & F. Stüber. (2006) Change of procalcitonin predicts clinical outcome of febrile episodes in patients with hematological malignancies. Supportive Care in Cancer 14:12, pages 1241-1245.
Crossref
L. Kitanovski, J. Jazbec, S. Hojker, M. Gubina & M. Derganc. (2006) Diagnostic accuracy of procalcitonin and interleukin-6 values for predicting bacteremia and clinical sepsis in febrile neutropenic children with cancer. European Journal of Clinical Microbiology & Infectious Diseases 25:6, pages 413-415.
Crossref
W. V. Kern. (2006) Risk Assessment and Treatment of Low-Risk Patients with Febrile Neutropenia. Clinical Infectious Diseases 42:4, pages 533-540.
Crossref
Eva Tavares, Rosario Maldonado, Maria L. Ojeda & Francisco J. Miñano. (2005) Circulating Inflammatory Mediators during Start of Fever in Differential Diagnosis of Gram-Negative and Gram-Positive Infections in Leukopenic Rats. Clinical and Vaccine Immunology 12:9, pages 1085-1093.
Crossref
Lennart Persson, Bo Soderquist, Per Engervall, Tomas Vikerfors, Lars-Olof Hansson & Ulf Tidefelt. (2005) Assessment of systemic inflammation markers to differentiate a stable from a deteriorating clinical course in patients with febrile neutropenia. European Journal of Haematology 74:4, pages 297-303.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.